Aldeyra Therapeutics Inc (ALDX)

Aug 14, 2025

Is Aldeyra Therapeutics Inc. stock a top performer YTDQuarterly Portfolio Review & Fast Momentum Stock Entry Tips - thegnnews.com

Aug 14, 2025

Aug 13, 2025

Aldeyra therapeutics CDO sells $113k in shares - Investing.com

Aug 13, 2025

Aug 08, 2025

Aldeyra Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Aug 08, 2025

Aug 08, 2025

Aldeyra price target raised to $9 from $6 at Jones Trading on FDA acceptance - Investing.com Canada

Aug 08, 2025

Aug 06, 2025

Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th A - GuruFocus

Aug 06, 2025

Aug 06, 2025

Aldeyra CEO to Share Exclusive Ophthalmology Pipeline Updates at H.C. Wainwright Conference - Stock Titan

Aug 06, 2025

Aug 04, 2025

AI Indicators Detect Buy Opportunity in Aldeyra Therapeutics Inc.Real-Time Analysis With Entry Targets In Progress - beatles.ru

Aug 04, 2025

Aug 03, 2025

Why is Aldeyra Therapeutics Inc. stock attracting strong analyst attentionTremendous portfolio expansion - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Aldeyra Therapeutics Inc. a good long term investmentBuild a portfolio that outperforms the market - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What makes Aldeyra Therapeutics Inc. stock price move sharplyFree Trend-Following Techniques - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How does Aldeyra Therapeutics Inc. generate profit in a changing economyPowerful profit generation - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Aldeyra Therapeutics Inc. stock in 2025Strongest growth potential - Jammu Links News

Aug 03, 2025

Aug 02, 2025

When is Aldeyra Therapeutics Inc. stock expected to show significant growthSky-high profits - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Published on: 2025-08-02 20:17:22 - beatles.ru

Aug 02, 2025

Aug 02, 2025

Is Aldeyra Therapeutics Inc. stock overvalued or undervaluedEarnings Report Alerts With Proven Results - Jammu Links News

Aug 02, 2025

Aug 01, 2025

What are analysts’ price targets for Aldeyra Therapeutics Inc. in the next 12 monthsWealth Building Insights That Work - Jammu Links News

Aug 01, 2025

Jul 31, 2025

How many analysts rate Aldeyra Therapeutics Inc. as a “Buy”AI Powered Entry Points That Work - Jammu Links News

Jul 31, 2025

Jul 31, 2025

Exploring US High Growth Tech Stocks For July 2025 - simplywall.st

Jul 31, 2025

Jul 30, 2025

Why Aldeyra Therapeutics Inc. stock attracts strong analyst attentionConsistent Gain Investment Strategies Emerge - metal.it

Jul 30, 2025

Jul 29, 2025

Published on: 2025-07-29 20:51:08 - metal.it

Jul 29, 2025

Jul 29, 2025

Trendline Breach Raises Concern for Aldeyra Therapeutics Inc. InvestorsCommunity Verified Stock Suggestions Drive Volume - metal.it

Jul 29, 2025

Jul 29, 2025

Why did ALDX's EPS remain stagnant in recent quarters? - AInvest

Jul 29, 2025

Jul 28, 2025

How Aldeyra Therapeutics Inc. stock performs during market volatilityFundamental Growth Stock Analysis Shows Strength - metal.it

Jul 28, 2025

Jul 28, 2025

How volatile is Aldeyra Therapeutics Inc. stock compared to the marketUnmatched market performance - Jammu Links News

Jul 28, 2025

Jul 27, 2025

What makes Aldeyra Therapeutics Inc. stock attractive to long term investorsAnalyst Grade Signals - metal.it

Jul 27, 2025

Jul 27, 2025

What is the risk reward ratio of investing in Aldeyra Therapeutics Inc. stockCapitalize on strategic market trends - Jammu Links News

Jul 27, 2025

Jul 27, 2025

What are Aldeyra Therapeutics Inc. company’s key revenue driversUnlock high-yield investment opportunities - jammulinksnews.com

Jul 27, 2025

Jul 26, 2025

Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA - Ophthalmology Times

Jul 26, 2025

Jul 24, 2025

Aldeyra Therapeutics Receives Orphan Designation from the Europe - GuruFocus

Jul 24, 2025

Jul 24, 2025

What drives Aldeyra Therapeutics Inc. stock priceFree Risk Assessment Services - printweek.in

Jul 24, 2025

Jul 24, 2025

What analysts say about Aldeyra Therapeutics Inc. stockExceptional gains - Autocar Professional

Jul 24, 2025

Jul 24, 2025

EMA grants orphan designation to ADX-2191 (Aldeyra Therapeutics) for inherited retinal dystrophies - Ophthalmology Times Europe

Jul 24, 2025

Jul 24, 2025

EMA grants orphan designation for Aldeyra’s eye treatment By Investing.com - Investing.com India

Jul 24, 2025

Jul 24, 2025

EMA grants orphan designation for Aldeyra’s eye treatment - Investing.com

Jul 24, 2025

Jul 24, 2025

Breakthrough: Aldeyra's Eye Drug Gets EU Orphan Status for Treating Incurable Genetic Blindness - Stock Titan

Jul 24, 2025

Jul 22, 2025

Published on: 2025-07-23 18:29:07 - Autocar Professional

Jul 22, 2025

Jul 22, 2025

Aldeyra Therapeutics Inc. Stock Analysis and ForecastSuperior returns - jammulinksnews.com

Jul 22, 2025